| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |